Autism future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
==Future or Investigational Therapies==
Although many [[Alternative therapies for developmental and learning disabilities|alternative therapies and interventions]] are available, few are supported by scientific studies.Lack of support for interventions:
Although many [[Alternative therapies for developmental and learning disabilities|alternative therapies and interventions]] are available, few are supported by scientific studies. Lack of support for interventions:
<ref>*{{cite journal |journal= Dev Med Child Neurol |date=2005 |volume=47 |issue=7 |pages=493–9 |title= Autism interventions: a critical update |author= Francis K |doi=10.1017/S0012162205000952 |pmid=15991872 |url=http://journals.cambridge.org/production/action/cjoGetFulltext?fulltextid=313204 |format=PDF}}
<ref>*{{cite journal |journal= Dev Med Child Neurol |date=2005 |volume=47 |issue=7 |pages=493–9 |title= Autism interventions: a critical update |author= Francis K |doi=10.1017/S0012162205000952 |pmid=15991872 |url=http://journals.cambridge.org/production/action/cjoGetFulltext?fulltextid=313204 |format=PDF}}
*{{cite journal |journal= J Autism Dev Disord |date=2008 |volume=38 |issue=2 |pages=353–61 |title= Social skills interventions for children with Asperger's syndrome or high-functioning autism: a review and recommendations |author= Rao PA, Beidel DC, Murray MJ |doi=10.1007/s10803-007-0402-4 |pmid=17641962}}
*{{cite journal |journal= J Autism Dev Disord |date=2008 |volume=38 |issue=2 |pages=353–61 |title= Social skills interventions for children with Asperger's syndrome or high-functioning autism: a review and recommendations |author= Rao PA, Beidel DC, Murray MJ |doi=10.1007/s10803-007-0402-4 |pmid=17641962}}
Line 11: Line 11:
Treatment approaches have little empirical support in [[quality of life|quality-of-life]] contexts, and many programs focus on success measures that lack predictive validity and real-world relevance. Scientific evidence appears to matter less to service providers than program marketing, training availability, and parent requests.<ref>{{cite journal |journal= Focus Autism Other Dev Disabl |date=2005 |volume=20 |issue=2 |pages=66–79 |title= Early intervention practices for children with autism: descriptions from community providers |author= Stahmer AC, Collings NM, Palinkas LA |pmid=16467905 |pmc=1350798}}</ref> Although most alternative treatments, such as [[melatonin]], have only mild adverse effects,<ref>{{cite journal |journal= Aust Fam Physician |year=2007 |volume=36 |issue=10 |pages=827–30 |title= Children and autism—part 2—management with complementary medicines and dietary interventions |author= Angley M, Semple S, Hewton C, Paterson F, McKinnon R |pmid=17925903 |url=http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2007issues/afp200710/200710angley.pdf |format=PDF}}</ref> a 2008 study found that autistic boys on [[Casein#Casein-free_diet|casein-free diets]] have significantly thinner bones,<ref>{{cite journal |journal= J Autism Dev Disord |date=2008 |volume=38 |issue=5 |pages=848–56 |title= Reduced bone cortical thickness in boys with autism or autism spectrum disorder |author= Hediger ML, England LJ, Molloy CA, Yu KF, Manning-Courtney P, Mills JL |doi=10.1007/s10803-007-0453-6 |pmid=17879151 |laysummary=http://www.nih.gov/news/health/jan2008/nichd-29.htm |laysource= NIH News |laydate=2008-01-29}}</ref> and botched [[chelation therapy]] killed a five-year-old autistic boy in 2005.<ref>{{cite journal |journal=Pediatrics |date=2006 |volume=118 |issue=2 |pages=e534-6 |title= Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005 |author= Brown MJ, Willis T, Omalu B, Leiker R |doi=10.1542/peds.2006-0858 |pmid=16882789 |url=http://pediatrics.aappublications.org/cgi/content/full/118/2/e534}}</ref>
Treatment approaches have little empirical support in [[quality of life|quality-of-life]] contexts, and many programs focus on success measures that lack predictive validity and real-world relevance. Scientific evidence appears to matter less to service providers than program marketing, training availability, and parent requests.<ref>{{cite journal |journal= Focus Autism Other Dev Disabl |date=2005 |volume=20 |issue=2 |pages=66–79 |title= Early intervention practices for children with autism: descriptions from community providers |author= Stahmer AC, Collings NM, Palinkas LA |pmid=16467905 |pmc=1350798}}</ref> Although most alternative treatments, such as [[melatonin]], have only mild adverse effects,<ref>{{cite journal |journal= Aust Fam Physician |year=2007 |volume=36 |issue=10 |pages=827–30 |title= Children and autism—part 2—management with complementary medicines and dietary interventions |author= Angley M, Semple S, Hewton C, Paterson F, McKinnon R |pmid=17925903 |url=http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2007issues/afp200710/200710angley.pdf |format=PDF}}</ref> a 2008 study found that autistic boys on [[Casein#Casein-free_diet|casein-free diets]] have significantly thinner bones,<ref>{{cite journal |journal= J Autism Dev Disord |date=2008 |volume=38 |issue=5 |pages=848–56 |title= Reduced bone cortical thickness in boys with autism or autism spectrum disorder |author= Hediger ML, England LJ, Molloy CA, Yu KF, Manning-Courtney P, Mills JL |doi=10.1007/s10803-007-0453-6 |pmid=17879151 |laysummary=http://www.nih.gov/news/health/jan2008/nichd-29.htm |laysource= NIH News |laydate=2008-01-29}}</ref> and botched [[chelation therapy]] killed a five-year-old autistic boy in 2005.<ref>{{cite journal |journal=Pediatrics |date=2006 |volume=118 |issue=2 |pages=e534-6 |title= Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005 |author= Brown MJ, Willis T, Omalu B, Leiker R |doi=10.1542/peds.2006-0858 |pmid=16882789 |url=http://pediatrics.aappublications.org/cgi/content/full/118/2/e534}}</ref>


Approximately twelve research studies are published each week on autism therapies. Three major barriers inhibit transfer of this information from the laboratory to the child:
* Treatment providers do not routinely turn to treatments that have been validated scientifically.
* A large minority of patients (actually parents of patients) resist therapies that have been scientifically validated.
* Even scientifically validated therapies are not universally effective.<ref>{{cite journal |journal= Ment Retard Dev Disabil Res Rev |year=2004 |volume=10 |issue=4 |pages=318–26 |title=Treating the core features of autism: are we there yet? |author= Bodfish JW |doi=10.1002/mrdd.20045 |pmid=15666340}}</ref>
==References==
==References==


Line 16: Line 20:
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Patient information]]
[[Category:Psychiatry]]
[[Category:Psychiatry]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
Line 24: Line 27:
[[Category:Autism]]
[[Category:Autism]]
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Needs overview]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 00:48, 11 February 2013

Autism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Behavioral Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autism future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autism future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autism future or investigational therapies

CDC on Autism future or investigational therapies

Autism future or investigational therapies in the news

Blogs on Autism future or investigational therapies

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Autism future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Future or Investigational Therapies

Although many alternative therapies and interventions are available, few are supported by scientific studies. Lack of support for interventions: [1] Treatment approaches have little empirical support in quality-of-life contexts, and many programs focus on success measures that lack predictive validity and real-world relevance. Scientific evidence appears to matter less to service providers than program marketing, training availability, and parent requests.[2] Although most alternative treatments, such as melatonin, have only mild adverse effects,[3] a 2008 study found that autistic boys on casein-free diets have significantly thinner bones,[4] and botched chelation therapy killed a five-year-old autistic boy in 2005.[5]

Approximately twelve research studies are published each week on autism therapies. Three major barriers inhibit transfer of this information from the laboratory to the child:

  • Treatment providers do not routinely turn to treatments that have been validated scientifically.
  • A large minority of patients (actually parents of patients) resist therapies that have been scientifically validated.
  • Even scientifically validated therapies are not universally effective.[6]

References

  1. *Francis K (2005). "Autism interventions: a critical update" (PDF). Dev Med Child Neurol. 47 (7): 493–9. doi:10.1017/S0012162205000952. PMID 15991872.
  2. Stahmer AC, Collings NM, Palinkas LA (2005). "Early intervention practices for children with autism: descriptions from community providers". Focus Autism Other Dev Disabl. 20 (2): 66–79. PMC 1350798. PMID 16467905.
  3. Angley M, Semple S, Hewton C, Paterson F, McKinnon R (2007). "Children and autism—part 2—management with complementary medicines and dietary interventions" (PDF). Aust Fam Physician. 36 (10): 827–30. PMID 17925903.
  4. Hediger ML, England LJ, Molloy CA, Yu KF, Manning-Courtney P, Mills JL (2008). "Reduced bone cortical thickness in boys with autism or autism spectrum disorder". J Autism Dev Disord. 38 (5): 848–56. doi:10.1007/s10803-007-0453-6. PMID 17879151. Lay summaryNIH News (2008-01-29).
  5. Brown MJ, Willis T, Omalu B, Leiker R (2006). "Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005". Pediatrics. 118 (2): e534–6. doi:10.1542/peds.2006-0858. PMID 16882789.
  6. Bodfish JW (2004). "Treating the core features of autism: are we there yet?". Ment Retard Dev Disabil Res Rev. 10 (4): 318–26. doi:10.1002/mrdd.20045. PMID 15666340.

Template:WH Template:WS